ABOUT: A biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals.
FUNDING: Completed the series seed financial round with $7.85 million in July 2022.
INVESTMENT: A $100,000 UMDF research grant has been converted to equity.
FINANCING STATUS: Venture Capital-Backed
Interested in having
The Mito Fund
in your company?
More Portfolio Announcements